选择性采用MPCNL和URL治疗输尿管上段结石的疗效比较

来源 :中国实用医药 | 被引量 : 0次 | 上传用户:nc_xujian
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的比较采用微创经皮肾穿刺取石术(MPCNL)和经尿道输尿管镜碎石取石术(URL)治疗输尿管上段结石的疗效。方法采用回顾性分析方法对86例输尿管上段结石,56例选用MPCNL治疗,30例选用URL治疗,并对临床资料进行分析。结果 MPCNL组一周结石清除率98.2%,一个月后结石清除率达100%,URL组一周结石清除率66.7%,其余病例因结石上移肾内需结合ESWL,联合ESWL一个月后结石清除率达96.7%。结论对输尿管结石的治疗,应根据患者的实际情况,选择性采用MPCNL和URL、或结合ESWL,二者均有较高的手术成功率。 Objective To compare the efficacy of minimally invasive percutaneous nephrolithotomy (MPCNL) and transurethral ureterolithotomy (URL) in the treatment of upper ureteral calculi. Methods A retrospective analysis of 86 cases of upper ureteral calculi, 56 cases selected MPCNL treatment, 30 cases selected URL treatment, and clinical data were analyzed. Results The stone clearance rate in one week was 98.2% in MPCNL group, 100% in one month, 66.7% in one week in URL group, and in ESWL group in the other cases due to the upper urinary stone metastasis. The stone clearance rate in one month after ESWL was 96.7 %. Conclusion The treatment of ureteral calculi should be based on the actual situation of patients, the selective use of MPCNL and URL, or combined with ESWL, both have a higher success rate of surgery.
其他文献
期刊
The recent approval of pembrolizumab as second-line treatment for any solid tumor with high-level microsatellite instability or mismatch repair deficiency agnos
期刊
期刊
期刊
目的应用主观全面评定法(SGA)对维持性血液透析(MHD)患者的营养状况进行评价。方法采用SGA结合有关生化指标,人体测量指标和饮食评估,对90例MHD患者的营养状况进行综合评价。
Cellular growth, development, and differentiation are tightly controlled by a conserved biological mechanism: the cell cycle. This cycle is primarily regulated
期刊
期刊
期刊
期刊